I would recommend for the purposes of this class narrowing your focus to either reducing signma or increasing access. How would you measure increasing access though ? It may just be a yes or no question. I would focus on the reducing stigma if it were me. Also, collecting demographics is a given. Is there a specific reason those would be outcome variables? Will they be used in another other way than to describe the population?
Exposure therapy for PtSD
Describe the intervention (what is it meant to impact) and its target population and the length and format (individual or group therapy, typically) for its delivery. Section Two: ▪ Summarize at least 2 studies that evaluated the intervention with an experimental design that evaluates the intervention quantitatively. These studies should